Displaying 1 - 20 of 512 in total

ATS Breathe Easy - Engineered Stone, Silicosis, and the Fight to Protect Workers

 There has been a sharp spike in silicosis diagnoses among workers who work with engineered stone countertops. The ATS released a report in 2026 on the subject, “Silic...

ATS Breathe Easy - ATS 2026: How Data Science and Precision Medicine go Hand-in-Hand

Clinicians and medical providers rely on data to tailor care plans to their patients. Aartik Sarma, MD, University of California, San Francisco, Pat Lyons, MD, Oregon ...

ATS Breathe Easy - ATS 2026: How A New Oral Medication Could Change OSA Treatment

The most common treatment for obstructive sleep apnea (OSA) is an at-home CPAP machine, but patients often remove their mask in their sleep or stop using the machine a...

ATS Breathe Easy - ATS 2026: Improving Urban Air Quality, One Result at a Time

Cities are working to make congestion zones safer for their populations, especially for sensitive groups like children and those with respiratory conditions. Emilia Si...

ATS Breathe Easy - How Funding Cuts Could Endanger Tuberculosis Research

 Tuberculosis is a difficult, infectious respiratory disease, and patients often have a low quality of life. Organizations like the ATS and the International Union Aga...

ATS Breathe Easy – ATS 2026: New Pavlov Study Could Help Sleep Apnea Patients Rest Easier

Obstructive sleep apnea (OSA) is a condition that affects millions globally, causing daytime sleepiness, lack of oxygen, and higher risks of developing cardiac issues....

ATS Breathe Easy - Innovations in Idiopathic Pulmonary Fibrosis Care

Idiopathic pulmonary fibrosis (IPF) is a progressive and often fatal lung disease, which has unknown causes and no cure. But researchers are working tirelessly to unco...

ATS Breathe Easy - ATS 2026: How a Rare Genetic Disorder Could Change Lung Disease Care

Hermansky-Pudlak syndrome (HPS) is a rare genetic disorder that causes albinism, bleeding problems, and a high risk of developing pulmonary fibrosis. However, patients...

ATS Breathe Easy - Understanding NTM Lung Disease

On this episode of the ATS Breathe Easy podcast, delve into journalist Terry Greene Sterling’s journey of being diagnosed with nontuberculous mycobacterial (NTM) lung ...

ATS Breathe Easy - ATS 2026: Delving into the Future of Rare Lung Disease

Lymphangioleiomyomatosis (LAM) is a rare lung disease that has become more treatable thanks to dedicated efforts from researchers and patient advocacy groups. ATS Past...

ATS Breathe Easy: Tackling Bacterial Pneumonia in ICU Patients

Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) are serious conditions that often affect critically ill patients in I...

ATS Breathe Easy – Hantavirus: Beyond the Headlines with ATS Expert, Dr. Michelle Harkins

When news of the Andes strain of the hantavirus broke out, the world seemed to hold its breath. But what do we know about the hantavirus? Expert Michelle Harkins, MD, ...

Re-Release: ATS Breathe Easy - ATS 2026 Keynotes Preview

Host Ugo Ezema, MD, Tulane University, speaks with University of Cincinnati's Laurah Turner, PhD, one of ATS 2026's keynote speakers who addressed the hot topic of AI ...

ATS Breathe Easy – How Pulse Oximeters Lead to Delayed Care for Patients of Color

Pulse oximetry is a key technology, providing a quick, non-invasive way to estimate blood oxygen levels. But one issue with this tool is that it can overestimate oxyge...

ATS Breathe Easy: ATS 2026 Keynotes Preview, Part 2

ATS 2026 is quickly approaching, and with so many great events, attendees are sure to enjoy every minute of the conference. On this second keynote preview, host Ugo Ez...

ATS Breathe Easy: ATS 2026 Keynotes Preview, Part 1

ATS 2026 is quickly approaching! This iteration of the international conference will feature amazing panels, speakers, and forums. On this episode of the ATS Breathe E...

ATS Breathe Easy - Why Advocating for Vaccines is Key to a Healthy Future

 Vaccines are essential to public health, yet the current Department of Health and Human Service leadership has led changes in vaccine recommendations that are not gro...

ATS Breathe Easy - The ATS AI Taskforce is Tackling Technological Questions

Artificial intelligence is at the center of dozens of new tools and technological advances, but how should clinicians and researchers integrate them into their practic...

ATS Breathe Easy – Advancements and Challenges in Sarcoidosis Research

 April is Sarcoidosis Awareness Month! Host Patti Tripathi speaks with Mary McGowan, president and CEO of the Foundation for Sarcoidosis Research, about the importance...

ATS Breathe Easy - How Much Is A Life Worth? Ask the EPA, Part 2

  The U.S. Environmental Protection Agency (EPA) changed the dollar value of a statistical life in January 2026, essentially dropping it to zero. What does that mean f...

© 2025 American Thoracic Society